What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Steven A. Narod spends much of his time researching Breast cancer, Internal medicine, Oncology, Cancer and Ovarian cancer.
His work carried out in the field of Breast cancer brings together such families of science as Odds ratio, Cancer research, Gynecology and Risk factor.
In his work, Germline and Carcinoma is strongly intertwined with Germline mutation, which is a subfield of Internal medicine.
His Oncology study integrates concerns from other disciplines, such as Chemotherapy, Case-control study, Mammary gland, Mutation and Prospective cohort study.
His research ties Surgery and Cancer together.
His Ovarian cancer research integrates issues from Genetic counseling, Serous fluid and Disease, Age of onset.
His most cited work include:
- A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 (5177 citations)
- Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies (2742 citations)
- Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence (2725 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Breast cancer, Internal medicine, Oncology, Cancer and Ovarian cancer.
Steven A. Narod has included themes like Gynecology, Family history, Genetic testing and Risk factor in his Breast cancer study.
The study incorporates disciplines such as Prophylactic Oophorectomy, Epidemiology and Obstetrics in addition to Gynecology.
In Oncology, Steven A. Narod works on issues like Germline mutation, which are connected to Germline.
Steven A. Narod has researched Cancer in several fields, including CHEK2, Cancer research and Genotype.
His Ovarian cancer research includes elements of Oophorectomy and Serous fluid.
He most often published in these fields:
- Breast cancer (73.43%)
- Internal medicine (71.45%)
- Oncology (62.77%)
What were the highlights of his more recent work (between 2016-2021)?
- Breast cancer (73.43%)
- Internal medicine (71.45%)
- Oncology (62.77%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Breast cancer, Internal medicine, Oncology, Cancer and Ovarian cancer.
He is interested in BRCA mutation, which is a field of Breast cancer.
His Internal medicine research focuses on Mutation and how it relates to Allele.
His study explores the link between Oncology and topics such as Germline mutation that cross with problems in Cancer research.
Steven A. Narod works in the field of Cancer, namely Mastectomy.
The concepts of his Ovarian cancer study are interwoven with issues in Oophorectomy, Gynecology and Serous fluid.
Between 2016 and 2021, his most popular works were:
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer (155 citations)
- Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (123 citations)
- Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers. (58 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Internal medicine, Breast cancer, Oncology, Cancer and Ovarian cancer.
His Internal medicine study typically links adjacent topics like Germline.
Steven A. Narod combines subjects such as Genetic testing, Cohort study, Cohort and Hazard ratio with his study of Breast cancer.
His Oncology study incorporates themes from Epidemiology, Young adult, Mortality rate, Lymph and Metastasis.
His biological study spans a wide range of topics, including Prospective cohort study and Bioinformatics.
His Ovarian cancer research incorporates themes from Germline mutation, Gynecology, Serous fluid and Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
